High-dose chemotherapy with haematopoietic stem cell rescue has proven
to be an effective treatment in relapsed lymphoma and neuroblastoma,
This treatment approach Should be considered also in selected patients
with leukaemia, multiple myeloma, breast cancer, ovarian cancer and t
esticular cancer, Relative contraindications include progression of th
e disease on appropriate conventional treatment, poor performance stat
us, active infection as well as serious renal, pulmonary, liver and ca
rdiac dysfunction. Increasing age should also be taken into considerat
ion when autologous stem cell transplantation is planned, Every effort
should be made to eliminate malignant cells that can be present in th
e stem cell containing population, which will be infused to the patien
t following myeloablative treatment.